8SUZ

Open State of the SARS-CoV-2 Envelope Protein Transmembrane Domain, Determined by Solid-State NMR


SOLID-STATE NMR
NMR Experiment
ExperimentTypeSample ContentsSolventIonic StrengthpHPressureTemperature (K)Spectrometer
12D 15N-13C15.5 % w/w [U-99% 13C; U-99% 15N] ETM, 23 % w/w POPC, 3.5 % w/w POPS, 10 % w/w POPE, 8 % w/w PI, 4 % w/w Cholesterol, 36 % w/w Water, 30 mM sodium acetate, 30 mM calcium chloride, 10 mM sodium chloride95% H2O/5% D2O1 M4.51 atm283Bruker AVANCE III 800
22D 13C-detected CORD15.5 % w/w [U-99% 13C; U-99% 15N] ETM, 23 % w/w POPC, 3.5 % w/w POPS, 10 % w/w POPE, 8 % w/w PI, 4 % w/w Cholesterol, 36 % w/w Water, 30 mM sodium acetate, 30 mM calcium chloride, 10 mM sodium chloride95% H2O/5% D2O1 M4.51 atm283Bruker AVANCE III 800
32D 1H-15N CP HETCOR15.5 % w/w [U-99% 13C; U-99% 15N] ETM, 23 % w/w POPC, 3.5 % w/w POPS, 10 % w/w POPE, 8 % w/w PI, 4 % w/w Cholesterol, 36 % w/w Water, 30 mM sodium acetate, 30 mM calcium chloride, 10 mM sodium chloride95% H2O/5% D2O1 M4.51 atm283Bruker AVANCE III 800
42D 15N-13C PSD7.5 % w/w [U-99% 15N; U-80% 2H] ETM, 8 % w/w [U-100% 13C] ETM, 23 % w/w POPC, 3.5 % w/w POPS, 10 % w/w POPE, 8 % w/w PI, 4 % w/w Cholesterol, 36 % w/w Water, 30 mM sodium acetate, 30 mM calcium chloride, 10 mM sodium chloride95% H2O/5% D2O1 M4.51 atm273Bruker AVANCE II 900
53D HNCA15.5 % w/w [U-99% 13C; U-99% 15N] ETM, 23 % w/w POPC, 3.5 % w/w POPS, 10 % w/w POPE, 8 % w/w PI, 4 % w/w Cholesterol, 36 % w/w Water, 30 mM sodium acetate, 30 mM calcium chloride, 10 mM sodium chloride95% H2O/5% D2O1 M4.51 atm283Bruker AVANCE III 800
63D HN(CO)CA15.5 % w/w [U-99% 13C; U-99% 15N] ETM, 23 % w/w POPC, 3.5 % w/w POPS, 10 % w/w POPE, 8 % w/w PI, 4 % w/w Cholesterol, 36 % w/w Water, 30 mM sodium acetate, 30 mM calcium chloride, 10 mM sodium chloride95% H2O/5% D2O1 M4.51 atm283Bruker AVANCE NEO 600
71D 19F 13C-detected REDOR7.5 % w/w [U-100% 13C; U-100% 15N; U-80% 2H] ETM, 8 % w/w 4-19F-Phe20-ETM, 23 % w/w POPC, 11 % w/w POPS, 10 % w/w POPE, 4.5 % w/w Cholesterol, 36 % w/w Water, 30 mM sodium acetate, 30 mM calcium chloride, 10 mM sodium chloride95% H2O/5% D2O1 M4.51 atm283Bruker AVANCE NEO 600
82D 19F 1H-15N 1H-detected CP HETCOR4.5 % w/w [U-99% 13C; U-99% 15N] ETM, 4 % w/w 4-19F-Phe20-ETM, 36.5 % w/w DMPC, 16 % w/w DMPG, 39 % w/w Water, 30 mM sodium acetate, 30 mM calcium chloride, 10 mM sodium chloride95% H2O/5% D2O1 M4.51 atm283Bruker AVANCE NEO 600
93D NCa-filtered 13C-detected DIPSHIFT8.5 % w/w [U-99% 13C; U-99% 15N] ETM, 35 % w/w POPC, 15.5 % w/w POPG, 59 % w/w Water, 30 mM sodium acetate, 30 mM calcium chloride, 10 mM sodium chloride95% H2O/5% D2O1 M4.51 atm331Bruker AVANCE III 800
NMR Spectrometer Information
SpectrometerManufacturerModelField Strength
1BrukerAVANCE II900
2BrukerAVANCE III800
3BrukerAVANCE NEO600
NMR Refinement
MethodDetailsSoftware
simulated annealingX-PLOR NIH
NMR Ensemble Information
Conformer Selection Criteriastructures with the lowest energy
Conformers Calculated Total Number3000
Conformers Submitted Total Number10
Representative Model1 (medoid)
Computation: NMR Software
#ClassificationVersionSoftware NameAuthor
1collectionTopSpinBruker Biospin
2data analysisTopSpinBruker Biospin
3chemical shift assignmentCcpNmr AnalysisCCPN
4refinementX-PLOR NIHSchwieters, Kuszewski, Tjandra and Clore
5structure calculationX-PLOR NIHSchwieters, Kuszewski, Tjandra and Clore